SMTL ID : 4tyd.1 (3 other biounits)

Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.84 Å

Oligo State

homo-trimer

Ligands

3 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: C.98, T.99, C.100, C.146, H.150 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:C.98, A:C.100, A:C.146 ZN.4: 5 residues within 4Å: Chain B: C.98, T.99, C.100, C.146, H.150 3 PLIP interactions: 3 interactions with chain B Metal complexes: B:C.98, B:C.100, B:C.146 ZN.6: 5 residues within 4Å: Chain C: C.98, T.99, C.100, C.146, H.150 3 PLIP interactions: 3 interactions with chain C Metal complexes: C:C.98, C:C.100, C:C.146

3 x 3EO: (4R,6S,7Z,15S,17S)-17-[({7-methoxy-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)methyl]-13-methyl-N-[(1-methylcyclopropyl)sulfonyl]-2,14-dioxo-1,3,13-triazatricyclo[13.2.0.0~4,6~]heptadec-7-ene-4-carboxamide(Non-covalent)

3EO.2: 25 residues within 4Å: Chain A: S.43, F.44, Y.57, H.58, G.59, V.79, D.80, D.82, V.133, L.136, K.137, G.138, S.139, S.140, F.155, R.156, A.157, A.158, D.169 Chain B: H.111, P.132, V.133, S.134, Y.135, G.163 19 PLIP interactions: 14 interactions with chain A, 5 interactions with chain B Hydrophobic interactions: A:F.44, A:V.133, A:K.137, A:F.155, A:F.155, A:R.156, A:A.158, B:P.132, B:P.132, B:Y.135 Hydrogen bonds: A:H.58, A:G.138, A:S.139, A:S.140, A:S.140, A:R.156, A:A.158, B:S.134 pi-Stacking: B:Y.135 3EO.5: 25 residues within 4Å: Chain B: Q.42, S.43, F.44, Y.57, H.58, G.59, V.79, D.82, V.133, K.137, G.138, S.139, S.140, F.155, R.156, A.157, A.158, C.160, D.169 Chain C: H.111, P.132, V.133, S.134, Y.135, G.163 21 PLIP interactions: 16 interactions with chain B, 5 interactions with chain C Hydrophobic interactions: B:F.44, B:D.82, B:V.133, B:F.155, B:F.155, B:R.156, B:A.157, B:A.158, C:P.132, C:P.132, C:V.133, C:Y.135 Hydrogen bonds: B:H.58, B:D.82, B:G.138, B:S.139, B:S.140, B:S.140, B:R.156, B:A.158, C:S.134 3EO.7: 26 residues within 4Å: Chain A: H.111, P.132, V.133, S.134, Y.135, G.163 Chain C: Q.42, S.43, F.44, Y.57, H.58, G.59, V.79, D.80, D.82, V.133, L.136, K.137, G.138, S.139, S.140, F.155, R.156, A.157, A.158, D.169 19 PLIP interactions: 4 interactions with chain A, 15 interactions with chain C Hydrophobic interactions: A:P.132, A:P.132, A:Y.135, C:F.44, C:D.82, C:V.133, C:L.136, C:F.155, C:R.156, C:A.157, C:A.158 Hydrogen bonds: A:S.134, C:H.58, C:G.138, C:S.139, C:S.140, C:S.140, C:R.156, C:A.158

4 x CL: CHLORIDE ION(Non-functional Binders)

CL.3: 2 residues within 4Å: Chain A: C.160, G.163 Ligand excluded by PLIP CL.8: 5 residues within 4Å: Chain B: L.22 Chain C: G.13, L.14, L.15, G.16 Ligand excluded by PLIP CL.9: 1 residues within 4Å: Chain C: D.113 Ligand excluded by PLIP CL.10: 1 residues within 4Å: Chain C: S.134 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Parsy, C. et al., Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease. Bioorg.Med.Chem.Lett. (2014)

Release Date

2014-09-10

Peptides

NS3 protease: ABC

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
D

C
F

NS3 protease

Related Entries With Identical Sequence